Adagloxad Simolenin/OBI-821 in Combination With TACE Therapy in HCC Patients With GALNT14-rs9679162-non-TT Genotype
Clinical trial NCT03608878 · TERMINATED
Trial details
- NCT number
- NCT03608878
- Sponsor
- Chang Gung Memorial Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-26
- Primary completion
- 2019-12-31
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.